NKGNW
NKGen Biotech, Inc. Warrants
NASDAQ · Healthcare · Biotechnology · US
$0.03
+2408.33%Margins
Gross margin
50.0%
EBITDA margin
-1033.9%
EBIT margin
-3682.7%
Net margin
-3612.6%
FCF margin
-3021.3%
46.8%
Return on equity
-148.7%
Return on assets
197.8%
Return on invested capital
0.08x
Asset turnover
-$19.6M
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2025